| BRmet50 |  | PMID18271932Sig33 | PMID16505416Sig822 | ||
---|---|---|---|---|---|---|
 | HR(95% CI) | HR P | HR (95% CI) | HR P | HR (95% CI) | HR P |
Tumor size | Â | Â | Â | Â | Â | Â |
T1 | 2.6(1.3-5.5) | 0.009 | 2.4(1.1-5.0) | 0.019 | 1.0(0.5-2.1) | 0.943 |
T2 | 1.7(1.0-2.8) | 0.044 | 2.0(1.3-3.3) | 0.008 | 0.7(0.4-1.2) | 0.209 |
Lymph node involvement | Â | Â | Â | Â | Â | Â |
No | 2.3(1.4-3.9) | 0.001 | 2.2(1.3-3.3) | 0.003 | 0.8(0.5-1.4) | 0.511 |
Yes | 2.0(1.0-4.1) | 0.053 | 2.8(1.4-5.0) | 0.004 | 0.6(0.3-1.4) | 0.245 |
Tamoxifen treatment | Â | Â | Â | Â | Â | Â |
No | 2.6(1.4-5.0) | 0.004 | 2.5(1.3-5.0) | 0.007 | 1.1(0.5-2.0) | 0.869 |
Yes | 2.2(1.2-3.9) | 0.007 | 2.6(1.4-5.0) | 0.001 | 0.6(0.3-1.0) | 0.041 |
Differentiation | Â | Â | Â | Â | Â | Â |
Good | 2.3(0.6-8.4) | 0.196 | 2.5(0.8-10) | 0.131 | 1.3(0.4-3.8) | 0.682 |
Intermediate | 2.5(1.5-4.3) | 0.001 | 3.3(2.0-5.0) | <0.001 | 0.7(0.4-1.2) | 0.194 |
Poor | 1.4(0.6-3.4) | 0.442 | 1.3(0.6-3.3) | 0.554 | 0.5(0.2-1.1) | 0.086 |
ER status | Â | Â | Â | Â | Â | Â |
Negative | 1.4(0.5-4.0) | 0.495 | 1.7(0.6-5.0) | 0.329 | 0.9(0.3-2.4) | 0.782 |
Positive | 2.5(1.6-4.0) | <0.001 | 2.5(1.7-5.0) | <0.001 | 0.7(0.4-1.1) | 0.102 |